相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytomegalovirus in transplantation -: challenging the status quo
Jay A. Fishman et al.
CLINICAL TRANSPLANTATION (2007)
Clinical proteomics: A need to define the field and to begin to set adequate standards
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
J. A. Khoury et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Benefits of cytomegalovirus prophylaxis in solid organ transplantation
Mark D. Pescovitz
TRANSPLANTATION (2006)
Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies
Nina Singh
JOURNAL OF CLINICAL VIROLOGY (2006)
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation
H Einsele et al.
BLOOD (2006)
American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
AC Kalil et al.
ANNALS OF INTERNAL MEDICINE (2005)
Messenger RNA for FOXP3 in the urine of renal-allograft recipients
T Muthukumar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
EM Hodson et al.
LANCET (2005)
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
M Haubitz et al.
KIDNEY INTERNATIONAL (2005)
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry:: Towards new diagnostic and therapeutic approaches
S Wittke et al.
ELECTROPHORESIS (2005)
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients
RB Freeman et al.
TRANSPLANTATION (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes
EM Weissinger et al.
KIDNEY INTERNATIONAL (2004)
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: The importance of HLA-DR matching
MA Schnitzler et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
S Sagedal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay
L von Müller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses
O Toupance et al.
TRANSPLANT INTERNATIONAL (2000)
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
S Sagedal et al.
TRANSPLANTATION (2000)
分享论文
